Biotechnology stocks have fared well year-to-date, and they even managed to recover well after a short-lived intra-week scare, closing the week near their highs. Among the pack, shares of Illumina, Inc. (NASDAQ:ILMN) stand out. ILMN stock looks ...
The time to buy Illumina is now. Illumina A few years ago, we wrote an article on Illumina (NASDAQ:ILMN) before the stock broke out in 2014-2015. Since the stock peaked in 2015 at $239.71, it has come down to $166.53 as of August 5, 2016. This is the same ...
Illumina Inc. (NASDAQ: ILMN) watched its shares slip early on Tuesday after the company issued an update on its sales for the third quarter. Unfortunately numbers came in below what analysts were looking for, and as a result investors sent the stock lower.
Illumina Inc. ILMN reported adjusted earnings per share (EPS ... Illumina's adjusted gross margin (considering stock-based compensation as regular expense) came in at 72.5%, reflecting a contraction of 70 basis points (bps) year over year, owing to ...
NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Illumina, Inc. …
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Illumina, Inc. (NASDAQ: ILMN ... Illumina stock dropped as much as 25% during ...
Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional …
We expect Illumina Inc ILMN to beat expectations when it reports fourth-quarter 2016 results after the closing bell on Jan 31. Last quarter, the company reported a positive earnings surprise of 11.49% with the four-quarter trailing average beat being 6.01%.
Big mistake. Over the course of 2013 and 2014, Illumina improved its annual revenue by 62%, more than doubled its net income, and — oh yeah — ILMN stock gained 250%. And there’s plenty more where that came from. Though the sequencing industry has ...
Just one year ago, the cost was $10,000. A decade ago, $1 billion. If ever there was a good story on capitalism and profit move, ILMN is it. It is also a Best Stock Now because this stock has the growth, performance, valuation, and stock chart that I like ...